Table 7.
Reference date | Overall |
AVF |
AVG |
PC |
|||||
---|---|---|---|---|---|---|---|---|---|
Male (n) | Female (n) | Male, n (%) | Female, n (%) | Male, n (%) | Female, n (%) | Male, n (%) | Female, n (%) | P-value | |
1.1.2001 | 30 | 19 | 28 (93) | 14 (74) | 2 (7) | 3 (16) | 0 | 2 (10) | 0.1 |
1.1.2002 | 35 | 26 | 32 (91) | 18 (69) | 2 (6) | 6 (23) | 1 (3) | 2 (8) | 0.06 |
1.1.2003 | 36 | 27 | 32 (89) | 18 (67) | 4 (11) | 8 (29) | 0 | 1 (4) | 0.07 |
1.1.2004 | 38 | 33 | 29 (76) | 24 (73) | 6 (16) | 7 (21) | 3 (8) | 2 (6) | 0.9 |
1.1.2005 | 43 | 35 | 37 (86) | 23 (66) | 5 (12) | 7 (20) | 1 (2) | 5 (14) | 0.07 |
1.1.2006 | 51 | 33 | 45 (88) | 24 (73) | 5 (10) | 5 (15) | 1 (2) | 4 (12) | 0.1 |
2001–2006 | 37 [30–51] | 30 [19–35] | 88.5% [76–93] | 71% [66–74] | 10.5% [6–16] | 20.5% [15–29] | 2% [0–8] | 9% [4–14] |
aData are displayed as counts (%) and median [range], P-value of difference between male and female (Fisher's exact test). Reference date: prevalent use rates were recorded at each 1st January from 2001 to 2006 for the second half of the study period. AVF, native arterio-venous fistula; AVG, arterio-venous graft; PC, permanent catheter.